| Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome (NCT02231879) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-10-14 |
| T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers (NCT02280811) | National Cancer Institute (NCI) | 2014-10-14 |
| Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy (NCT02262806) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2014-10-14 |
| Randomized, Double-blind, Controlled of MDMA-assisted Psychotherapy in 12 Subjects With PTSD (NCT01958593) | Resilient Pharmaceuticals | 2014-10-14 |
| Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer (NCT02289690) | AbbVie | 2014-10-13 |
| Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS) (NCT02269280) | M.D. Anderson Cancer Center | 2014-10-13 |
| Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations (NCT02304809) | UNICANCER | 2014-10-13 |
| Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema (NCT02348918) | Allegro Ophthalmics, LLC | 2014-10-13 |
| Vitamin D3 and the Stress-axis in MS (NCT02096133) | Academic MS Center Limburg | 2014-10-13 |
| Brentuximab Vedotin, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma (NCT02227199) | University of Washington | 2014-10-10 |
| Study Evaluating the Influence of LV5FU2 Bevacizumab Plus Anakinra Association on Metastatic Colorectal Cancer (NCT02090101) | Centre Georges Francois Leclerc | 2014-10-10 |
| Study of the Efficacy and Safety of MEDI4893 (NCT02296320) | MedImmune LLC | 2014-10-10 |
| Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC (NCT02268695) | Groupe Oncologie Radiotherapie Tete et Cou | 2014-10-10 |
| Sodium Bicarbonate Supplementation in Combat Sports Athletes (NCT03406065) | Poznan University of Life Sciences | 2014-10-10 |
| Albiglutide Versus Placebo in Insulin-treated Subjects With New-onset Type 1 Diabetes Mellitus (NCT02284009) | GlaxoSmithKline | 2014-10-10 |
| DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission (NCT02166905) | Roswell Park Cancer Institute | 2014-10-10 |
| Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer (NCT02143726) | Alliance for Clinical Trials in Oncology | 2014-10-09 |
| Extension Study to Evaluate Long-Term Effects of Luspatercept in Patients With Myelodysplastic Syndromes (MDS) (A536-05/MK-6143-003) (NCT02268383) | Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | 2014-10-09 |
| An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP) (NCT02279095) | Clementia Pharmaceuticals Inc. | 2014-10-09 |
| A Study to Evaluate the Pharmacokinetics, Safety,and Efficacy of Omacetaxine Given Subcutaneously as a Fixed Dose in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML) (Referred to as the SYNSINCT Study) (NCT02078960) | Teva Branded Pharmaceutical Products R&D, Inc. | 2014-10-09 |
| Non-Randomized Trial Assessing Pain Efficacy With Radium-223 in Symptomatic Metastatic Castration-Resistant Prostate Cancer (NCT02278055) | Memorial Sloan Kettering Cancer Center | 2014-10-08 |
| Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors (NCT01956669) | Novartis Pharmaceuticals | 2014-10-08 |
| Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus (NCT02015559) | Jonsson Comprehensive Cancer Center | 2014-10-08 |
| Safety and Tolerability of HSC835 in Patients With Hematological Malignancies Undergoing Single Umbilical Cord Blood Transplant (NCT01930162) | Novartis Pharmaceuticals | 2014-10-07 |
| A Single-Arm, Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Treatment Containing an Anti-CTLA4 Monoclonal Antibody (CheckMate 172) (NCT02156804) | Bristol-Myers Squibb | 2014-10-07 |
| Lapatinib Plus Trametinib in KRAS Mutant NSCLC (NCT02230553) | The Netherlands Cancer Institute | 2014-10-07 |
| VAgal Nerve Stimulation: safeGUARDing Heart Failure Patients (NCT02113033) | LivaNova | 2014-10-07 |
| Single-Agent Glasdegib In Patients With Myelofibrosis Previously Treated With Ruxolitinib (NCT02226172) | Pfizer | 2014-10-06 |
| Medytoxin® Treatment in Patients With Benign Masseteric Hypertrophy (NCT02292472) | Medy-Tox | 2014-10-06 |
| Adaptive Study of IL-2 Dose Frequency on Regulatory T Cells in Type 1 Diabetes (NCT02265809) | Cambridge University Hospitals NHS Foundation Trust | 2014-10-03 |
| BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST) (NCT02257541) | Memorial Sloan Kettering Cancer Center | 2014-10-02 |
| Comparing the Effectiveness of Two Dietary Interventions for Fecal Incontinence (NCT02828384) | University of Michigan | 2014-10-02 |
| Bicarbonate in Patients With Out-of-hospital Cardiac Arrest (NCT02303548) | Asan Medical Center | 2014-10-01 |
| An Open-Label Study , Safety and Tolerability of Brincidofovir for Post Exposure Prophylaxis of Ebola (NCT04268966) | Jazz Pharmaceuticals | 2014-10-01 |
| Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF) (NCT01875874) | Vital Therapies, Inc. | 2014-10-01 |
| Receptor Occupancy of ITI-007 Using Positron Emission Tomography (PET) in Patients With Stable Schizophrenia (NCT02288845) | Intra-Cellular Therapies, Inc. | 2014-10-01 |
| Phase 2a Study on Allogeneic Osteoblastic Cells Implantation in Lumbar Spinal Fusion (NCT02205138) | Bone Therapeutics S.A | 2014-10-01 |
| Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis (NCT02309385) | Aciont Inc | 2014-10-01 |
| Study 1: Effect of Minocycline Treatment on Drug-Resistant Hypertensive Patients (NCT02133872) | University of Florida | 2014-10-01 |
| A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Skin Pruritus (NCT02565134) | Amorepacific Corporation | 2014-10-01 |
| Establishing the Microcirculatory Effects of Ticagrelor on Tissue Perfusion in Critical Limb Ischemia (NCT02230527) | The Cleveland Clinic | 2014-10-01 |
| Safety, Tolerability, and Immunogenicity of GC3106 (Quadrivalent Cell-culture Based Influenza Vaccine) (NCT02249221) | Green Cross Corporation | 2014-10-01 |
| Treatments of the Necrosed Immature Teeth (REV) (NCT02064517) | University Hospital, Brest | 2014-10-01 |
| Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot Study (NCT02249026) | Gauda, Estelle B., M.D. | 2014-10-01 |
| Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors (NCT02108782) | Academic and Community Cancer Research United | 2014-10-01 |
| Study of SD-101 in Combination With Localized Low-dose Radiation in Patients With Untreated Low-grade B-cell Lymphoma (NCT02266147) | Dynavax Technologies Corporation | 2014-10-01 |
| Hylenex-Assisted Resuscitation in Kenya (HARK) Trial for the Management of Dehydration (NCT02265575) | Massachusetts General Hospital | 2014-10-01 |
| Efficacy of Rifaximin in Preventing Campylobacteriosis (NCT02280044) | Johns Hopkins Bloomberg School of Public Health | 2014-10-01 |
| A Phase IIa Study of Sotatercept on Bone Mass and Turnover in Patients With Multiple Myeloma (NCT02230917) | Rebecca Silbermann | 2014-10-01 |
| Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer Patients (NCT02239731) | Vyne Therapeutics Inc. | 2014-10-01 |
| Metformin in Kidney Disease (NCT02252081) | VA Office of Research and Development | 2014-10-01 |
| Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation (NCT02259348) | St. Jude Children's Research Hospital | 2014-10-01 |
| Pharmacokinetics of Micafungin Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients at Risk for Developing an Invasive Fungal Disease (NCT02172768) | Radboud University Medical Center | 2014-10-01 |
| Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT (NCT02294552) | Ivan S Moiseev | 2014-10-01 |
| Safety and Efficacy Study of SUN 131 TDS as Compared to Placebo TDS in Adult Patients With a Chalazion (NCT02338648) | Senju USA, Inc. | 2014-10-01 |
| Evaluate the Response to 2 Induction Courses (12 Intravesical Instillations) of Bacillus Calmette-Guérin (BCG) for High Risk Superficial Bladder Cancer (NCT02281383) | Memorial Sloan Kettering Cancer Center | 2014-10-01 |
| RDEA3170 and Febuxostat Combination Study in Gout Subjects (NCT02246673) | Ardea Biosciences, Inc. | 2014-10-01 |
| Phase 2, Open-Label Study for Safety, Microbiology and PK of Single or Multiple Oral C16G2 Gel Doses (NCT02254993) | Armata Pharmaceuticals, Inc. | 2014-10-01 |
| Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer (NCT02318901) | Western Regional Medical Center | 2014-10-01 |
| A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Rosacea (NCT02583009) | Amorepacific Corporation | 2014-10-01 |
| Safety Evaluation of 3K3A-APC in Ischemic Stroke (NCT02222714) | ZZ Biotech, LLC | 2014-10-01 |
| A Multicenter Assessment of ALD403 in Chronic Migraine (NCT02275117) | Alder Biopharmaceuticals, Inc. | 2014-10-01 |
| Placebo- Controlled Study to Evaluate the Safety and Immunogenicity of the RSV-F Vaccine in Elderly Adults (NCT02266628) | Novavax | 2014-10-01 |
| A Randomized, Placebo-controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of F8IL10 (Dekavil) in Patients With Active RA Receiving MTX (NCT02270632) | Philogen S.p.A. | 2014-10-01 |
| Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402) (NCT02288078) | Clinical Research Support Center Kyush | 2014-10-01 |
| A Study to Evaluate the Efficacy and Safety of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma) (NCT02283957) | Centrexion Therapeutics | 2014-10-01 |
| Sequential Melphalan for Use With Hepatic Delivery System Treatment Followed by Sorafenib in Patients With Unresectable HCC (NCT02406508) | Delcath Systems Inc. | 2014-10-01 |
| Treatment of Suspected Cholelithiasis With Nitroglycerin (NCT01715220) | United States Naval Medical Center, San Diego | 2014-10-01 |
| H7N9 Mix and Match With MF59 in Healthy Elderly Persons (NCT02213354) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-10-01 |
| Caffeine in Amblyopia Study (NCT02594358) | Johns Hopkins University | 2014-10-01 |
| A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy (NCT02215330) | Prim. Prof. Dr. Oliver Findl, MBA | 2014-10-01 |
| Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial (NCT02175225) | Beth Israel Deaconess Medical Center | 2014-10-01 |
| Study of A-101 for the Treatment of Seborrheic Keratosis (NCT02260180) | Aclaris Therapeutics, Inc. | 2014-10-01 |
| A Study Evaluating RO5479599 in Combination With Carboplatin and Paclitaxel in Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) of Squamous Histology (NCT02204345) | Hoffmann-La Roche | 2014-10-01 |
| Efficacy and Safety of SPARC1310 in Seasonal Allergic Rhinitis (NCT01940146) | Sun Pharma Advanced Research Company Limited | 2014-10-01 |
| Carfilzomib, Cyclophosphamide, Dexamethasone in Transplant Eligible Newly Diagnosed High-risk Multiple Myeloma (NCT02217163) | Singapore General Hospital | 2014-10-01 |
| A Phase 1/2a Study of LON002 in Subjects With Advanced Solid Tumours (NCT02263950) | LondonPharma Ltd. | 2014-10-01 |
| The Efficacy of Individualised Homeopathic Treatment on Constipation (NCT02411175) | University of Johannesburg | 2014-10-01 |
| A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN (NCT02126969) | Susanne Arnold | 2014-10-01 |
| Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR) (NCT02286258) | Assistance Publique - Hôpitaux de Paris | 2014-10-01 |
| PCI and Renal Denervation in Hypertensive Patients With Acute Coronary Syndromes (NCT02272920) | Sahlgrenska University Hospital | 2014-10-01 |
| Effect of Lamotrigine on Cognition in NF1 (NCT02256124) | Erasmus Medical Center | 2014-10-01 |
| Intra-operative Infra-red Fluorescent Imaging in Thyroid and Parathyroid Surgery (NCT02089542) | Sheffield Teaching Hospitals NHS Foundation Trust | 2014-10-01 |
| Dose Finding Safety Study of VAL201 in Cancer Patients (NCT02280317) | ValiRx Plc | 2014-10-01 |
| SYL040012, Treatment for Open Angle Glaucoma (NCT02250612) | Sylentis, S.A. | 2014-10-01 |
| Prevention of Paclitaxel Neuropathy With Cryotherapy (NCT02230319) | Medical Oncology & Hematology Associates of Northern Virginia | 2014-10-01 |
| Study to Evaluate the Efficacy of HepaStem in Urea Cycle Disorders Paediatric Patients (HEP002) (NCT02489292) | Cellaion SA | 2014-10-01 |
| NY-ESO-1 T Cells in OG Cancer (NCT01795976) | Fiona Thistlethwaite | 2014-10-01 |
| Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma (NCT02279134) | Zefen Xiao | 2014-10-01 |
| Palliative Short-course Hypofractionated Radiotherapy Followed by Chemotherapy in Adenocarcinoma of the Esophagus or Esophagogastric Junction Trial - a Phase II Clinical Trial Protocol. (NCT02241499) | Lund University Hospital | 2014-10-01 |
| Ketamine and Glutamate After Brain Injury : a Microdialysis Study (NCT02232347) | Pierre-Julien CUNGI | 2014-10-01 |
| Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma (NCT02282358) | Memorial Sloan Kettering Cancer Center | 2014-10-01 |
| A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas (NCT02220855) | Patrick Joseph Loehrer Sr. | 2014-10-01 |
| Biomarker Correlates of Hypoxia in Metastatic Melanoma (NCT02061007) | H. Lee Moffitt Cancer Center and Research Institute | 2014-10-01 |
| To Evaluate the Effect of MCS® in Prostate Cancer Prevention (NCT02042807) | Health Ever Bio-Tech Co., Ltd. | 2014-10-01 |
| Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST) (NCT02203968) | Sunnybrook Health Sciences Centre | 2014-10-01 |
| Efficacy of Amicar for Children Having Craniofacial Surgery (NCT02229968) | Children's National Research Institute | 2014-10-01 |
| Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson's Disease (NCT02183519) | University of Florida | 2014-10-01 |
| Compare Dose Regimens of AllerT, in Adults With Allergic Rhino-Conjunctivitis to Birch Pollen Studied in EEC (NCT02271009) | Anergis | 2014-10-01 |
| A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia (NCT02251548) | Dana-Farber Cancer Institute | 2014-10-01 |